Verkazia (cyclosporine 0.1% ophthalmic emulsion) — United Healthcare
moderate to severe vernal keratoconjunctivitis
Preferred products
- ophthalmic antihistamines (e.g., azelastine, olopatadine)
- ophthalmic mast cell stabilizers (e.g., cromolyn sodium)
- ophthalmic corticosteroids (e.g., dexamethasone, prednisolone, fluorometholone)
Initial criteria
- Diagnosis of moderate to severe vernal keratoconjunctivitis
- AND History of failure, contraindication, or intolerance to two of the following categories: ophthalmic antihistamines (e.g., azelastine, olopatadine), ophthalmic mast cell stabilizers (e.g., cromolyn sodium), ophthalmic corticosteroids (e.g., dexamethasone, prednisolone, fluorometholone)
Reauthorization criteria
- Documentation of positive clinical response
Approval duration
12 months